Vicki L. Sato - Jul 30, 2021 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Jul 30, 2021
Transactions value $
$0
Form type
3
Date filed
8/3/2021, 05:28 PM
Previous filing
Jul 23, 2021
Next filing
Aug 20, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALLO Stock Option (Right to Buy) Jul 30, 2021 Common Stock 3K $36.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares subject to the stock option vested on October 31, 2020 and 50% of the shares subject to the stock option vested on February 28, 2021.